Geode Capital Management
MIRO

Geode Capital Management’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Geode Capital Management’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-173,776
Closed -$210K – 4732
2023
Q3 		$210K Sell
173,776
-14,000
-7% -$20.4K ﹤0.01% 3962
2023
Q2 		$329K Buy
187,776
+48,195
+35% +$63.6K ﹤0.01% 3815
2023
Q1 		$234K Hold
139,581
– – ﹤0.01% 3968
2022
Q4 		$417K Buy
139,581
+2,847
+2% +$11.2K ﹤0.01% 3745
2022
Q3 		$598K Buy
136,734
+89,645
+190% +$290K ﹤0.01% 3634
2022
Q2 		$187K Buy
47,089
+25,419
+117% +$97.4K ﹤0.01% 4306
2022
Q1 		$85K Buy
21,670
+9,860
+83% +$36.7K ﹤0.01% 4705
2021
Q4 		$54K Buy
11,810
+1,607
+16% +$11.4K ﹤0.01% 4847
2021
Q3 		$71K Buy
+10,203
New +$96.2K ﹤0.01% 4739

Geode Capital Management's MIRO Position: Q4 2023 in Review

Geode Capital Management sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 173,776 shares — an estimated $210K sold.

Geode Capital Management first reported a position in MIRO in Q3 2021 and held it in 9 quarters. The position peaked at $598K in Q3 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • Geode Capital Management reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 173,776 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $210K.
  • Geode Capital Management first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Geode Capital Management's Miromatrix Medical Inc. Common Stock position peaked at $598K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.